
    
      This study will take place over 3 years with a recruitment period of 18 months. After
      verification of the eligibility criteria and signature of the consent, the patients will be
      divided into 2 groups by randomization: the intervention group and the control group. The
      duration of participation of the subjects will be 12 months. Assessments are available in 4
      steps (V1 at inclusion, V2 at 3 months, V3 at 6 months and V4 at 12 months). These visits
      include an assessment of the functioning of patients, symptomatology, quality of life,
      treatment and care received at all visits, occupational activity and cognitive assessment and
      social knowledge at V1 and V4.
    
  